Accuray (ARAY) Invested Capital (2012 - 2026)
Accuray's (ARAY) quarterly Invested Capital came in at $11.2 million in Q1 2026, up 47.35% year-on-year from $7.6 million in Q1 2025, and little changed quarter-over-quarter from $11.1 million in Q4 2025.
Accuray (ARAY) Invested Capital (2012 - 2026) Analysis & Trends
Accuray's Invested Capital history runs 13 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- On a quarterly basis, Invested Capital rose 47.35% year-over-year to $11.2 million in Q1 2026; TTM through Mar 2026 was $47.9 million, a 56.09% increase from a year earlier, with the FY2025 full-year figure at $12.7 million, up 64.18% from the prior year.
- Invested Capital steadied at $11.2 million in Q1 2026 per ARAY's latest filing, from $11.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $12.9 million in Q3 2025 and bottomed at $5.7 million in Q4 2022.
- The 5-year median for Invested Capital is $7.6 million (2025), against an average of $8.1 million.
- Biggest YoY gain for Invested Capital was 125.94% in 2022; the steepest drop was 57.5% in 2022.
- Year by year, Invested Capital stood at $5.7 million in 2022, then grew by 18.17% to $6.7 million in 2023, then grew by 12.2% to $7.6 million in 2024, then jumped by 46.96% to $11.1 million in 2025, then increased by 0.45% to $11.2 million in 2026.
- Per Business Quant, the three latest ARAY Invested Capital figures stand at $11.2 million (Q1 2026), $11.1 million (Q4 2025), and $12.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 11.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.16 Mn |
| Dec 31, 2025 | 11.11 Mn |
| Sep 30, 2025 | 12.85 Mn |
| Jun 30, 2025 | 12.73 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | 7.77 Mn |
| Jun 30, 2024 | 7.76 Mn |
| Mar 31, 2024 | 7.25 Mn |
| Dec 31, 2023 | 6.74 Mn |
| Sep 30, 2023 | 6.23 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 5.70 Mn |
| Sep 30, 2022 | 5.71 Mn |
| Jun 30, 2022 | 8.56 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 7.54 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 3.79 Mn |